Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01789125 · ClinicalTrials.gov registry record · Phase 1
Smoking Termination / Anxiety Reduction Treatment (ST/ART)
A Phase 1 study, sponsored by University of Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01789125 is a Phase 1 study that has completed, run by University of Houston. The registered enrollment target is 74 participants.
The verdict
NCT01789125, a Phase 1 study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
The primary aim of this research study is to enhance smoking cessation outcome among smokers with anxiety disorders. The investigators are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation and anxiety treatment program (START). Both treatments also utilize nicotine replacement therapy.
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Smoking Termination and Anxiety Reduction Treatment
- BEHAVIORAL Education-Supportive Psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-03 |
| Est. Completion | 2016-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01789125
The ClinicalTrials.gov registry entry for NCT01789125 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT01789125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01789125 about?
NCT01789125 is a clinical study titled "Smoking Termination / Anxiety Reduction Treatment (ST/ART)". The primary aim of this research study is to enhance smoking cessation outcome among smokers with anxiety disorders. The investigators are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking ces...
What is the current status of trial NCT01789125?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01789125?
The interventions under investigation include: Nicotine Patch (DRUG), Smoking Termination and Anxiety Reduction Treatment (BEHAVIORAL), Education-Supportive Psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01789125?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.